Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $5,114 - $5,769
20 Added 9.39%
233 $67,000
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $285,338 - $354,255
-1,305 Reduced 85.97%
213 $57,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $29,783 - $35,218
139 Added 10.08%
1,518 $337,000
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $311,364 - $379,500
1,379 New
1,379 $333,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $376,643 - $424,785
-1,678 Reduced 46.66%
1,918 $432,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $474,801 - $528,370
2,058 Added 133.81%
3,596 $875,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $258,300 - $285,747
1,178 Added 327.22%
1,538 $372,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $23,467 - $26,856
118 Added 48.76%
360 $82,000
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $17,618 - $20,642
83 Added 52.2%
242 $51,000
Q2 2021

Aug 17, 2021

BUY
$233.58 - $259.14 $37,139 - $41,203
159 New
159 $39,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $146,703 - $194,568
-805 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $152,314 - $195,776
805 New
805 $194,000
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $618,264 - $740,809
-3,551 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $465,259 - $545,389
2,791 Added 367.24%
3,551 $654,000
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $133,264 - $155,562
-747 Reduced 49.57%
760 $145,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $229,203 - $258,396
-1,237 Reduced 45.08%
1,507 $312,000
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $705,380 - $792,294
-4,248 Reduced 60.76%
2,744 $507,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $55,742 - $65,142
329 Added 4.94%
6,992 $1.19 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $553,968 - $618,952
3,282 Added 97.07%
6,663 $1.16 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $565,607 - $645,771
3,381
3,381 $1.99 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.